EUVIMEDEUVIMED entdecken
Open Access

Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis

Matthew D Park iD, Jessica Le Berichel iD, Pauline Hamon iD, C Matthias Wilk iD, Meriem Belabed, Nader Yatim iD, Alexis Saffon iD, Jesse Boumelha iD, Chiara Falcomatà iD, Alexander Tepper iD, Samarth Hegde iD, Raphaël Mattiuz iD und 27 weitere

Science · 25.10.2024 · 386 (6720)

DOI: 10.1126/science.adn0327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 25.10.2024. Verfasst von Matthew D Park und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Aging, DNA Methyltransferase 3A, Interleukin-1alpha, Lung Neoplasms. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age is a major risk factor for cancer, but how aging impacts tumor control remains unclear. In this study, we establish that aging of the immune system, regardless of the age of the stroma and tumor, drives lung cancer progression. Hematopoietic aging enhances emergency myelopoiesis, resulting in the local accumulation of myeloid progenitor–like cells in lung tumors. These cells are a major source of interleukin (IL)–1⍺, which drives the enhanced myeloid response. The age-associated decline of DNA methyltransferase 3A enhances IL-1⍺ production, and disrupting IL-1 receptor 1 signaling early during tumor development normalized myelopoiesis and slowed the growth of lung, colonic, and pancreatic tumors. In human tumors, we identified an enrichment for IL-1⍺–expressing monocyte-derived macrophages linked to age, poorer survival, and recurrence, unraveling how aging promotes cancer and offering actionable therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingDNA Methyltransferase 3AInterleukin-1alphaLung NeoplasmsMacrophagesMyelopoiesisAnimalsHumansMiceHematopoiesisInterleukin-1betaMice, Inbred C57BLPancreatic NeoplasmsSignal Transduction

Substanzen

DNA Methyltransferase 3AInterleukin-1alphaInterleukin-1beta

Autor:innen und Institutionen

  • Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • INSERM U932, Immunity and Cancer, Institut Curie, Paris-Cité University, Paris, France.
  • Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Brain and Body Research Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

ORCID-Profile: Matthew D Park, Jessica Le Berichel, Pauline Hamon, C Matthias Wilk, Nader Yatim, Alexis Saffon, Jesse Boumelha, Chiara Falcomatà, Alexander Tepper, Samarth Hegde, Raphaël Mattiuz, Brian Y Soong, Frederika Rentzeperis, Leanna Troncoso, Laszlo Halasz, Theodore Chin, Earnest P Chen, Matthew Su, Darwin D'souza, Rachel Chen, Travis Dawson, Kai Nie, Zhihong Chen, Seunghee Kim-Schulze, Maria Casanova-Acebes, Filip K Swirski, Julian Downward, Thomas U Marron, Miriam Merad

Förderung

  • Wellcome Trust
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIEHS NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Park, M. D., Le Berichel, J., Hamon, P., Wilk, C. M., Belabed, M., Yatim, N., Saffon, A., Boumelha, J., Falcomatà, C., Tepper, A., Hegde, S., Mattiuz, R., Soong, B. Y., LaMarche, N. M., Rentzeperis, F., Troncoso, L., Halasz, L., Hennequin, C., Chin, T., …, & Merad, M. (2024). Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis. Science, 386(6720). https://doi.org/10.1126/science.adn0327

Vancouver

Park MD, Le Berichel J, Hamon P, Wilk CM, Belabed M, Yatim N, et al. Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis. Science. 2024;386(6720). doi:10.1126/science.adn0327

BibTeX
@article{Park2024,
  author = {Park, Matthew D and Le Berichel, Jessica and Hamon, Pauline and Wilk, C Matthias and Belabed, Meriem and Yatim, Nader and Saffon, Alexis and Boumelha, Jesse and Falcomatà, Chiara and Tepper, Alexander and Hegde, Samarth and Mattiuz, Raphaël and Soong, Brian Y and LaMarche, Nelson M and Rentzeperis, Frederika and Troncoso, Leanna and Halasz, Laszlo and Hennequin, Clotilde and Chin, Theodore and Chen, Earnest P and Reid, Amanda M and Su, Matthew and Cahn, Ashley Reid and Koekkoek, Laura L and Venturini, Nicholas and Wood-Isenberg, Shira and D'souza, Darwin and Chen, Rachel and Dawson, Travis and Nie, Kai and Chen, Zhihong and Kim-Schulze, Seunghee and Casanova-Acebes, Maria and Swirski, Filip K and Downward, Julian and Vabret, Nicolas and Brown, Brian D and Marron, Thomas U and Merad, Miriam},
  title = {Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis},
  journal = {Science},
  year = {2024},
  volume = {386},
  number = {6720},
  doi = {10.1126/science.adn0327}
}
Kostenlos starten →